Non-voltage-gated Ca²⁺ entry pathways in the heart: the untold STOrai?
Non-voltage-gated Ca²⁺ entry pathways in the heart: the untold STOrai?
复制标题
心脏中的非电压门控 Ca2+ 进入途径:不为人知的 STOrai?
DOI:
10.1093/cvr/cvu217
复制
发表时间:
2015
影响因子:
10.8
通讯作者:
Chatham,JohnC
中科院分区:
文献类型:
--
作者:
Collins,HelenE;Chatham,JohnC
Our understanding of cardiomyocyte Ca2+ handling is primarily based on the regulation of voltage-gated Ca2+ entry, via L-type Ca2+ channels (LTCCs), and the resulting Ca2+-induced Ca2+ release from the sarcoplasmic reticulum (SR) required for excitation–contraction coupling. Ca2+ is widely recognized as playing a key signalling role in all cells, and in cardiomyocytes the most commonly accepted pathway involves Ca2+ release from intracellular stores such as the endoplasmic reticulum (ER)/SR and the nuclear envelope. However, in non-excitable cells, agonist-mediated increases in intracellular Ca2+ are known to occur as a result of Ca2+ entry across the plasma membrane. The most widely studied of these pathways is store-operated Ca2+ entry (SOCE) as described by Putney 1 where Inositol 1, 4, 5 Triphosphate (IP3)-induced release of Ca2+ from ER/SR stores triggered a subsequent influx of extracellular Ca2+, which was required both for subsequent activation of downstream signalling pathways and also for refilling of ER/SR. Such Ca2+ signals have been shown to play a key role in the regulation of diverse cellular responses, including metabolism, transcription, and differentiation. One of the earliest reports demonstrating that SOCE contributed to Ca2+ signalling in cardiomyocytes was in 2002 where Marchase and colleagues 2 showed that activation of nuclear factor of activated T-cells (NFAT) by phenylephrine or angiotensin and the resulting cardiomyocyte hypertrophy was SOCE-dependent. At that time the proteins responsible for regulating SOCE were unknown; however, in 2005 with the identification of stromal interaction molecule (STIM) and Orai protein families, the molecular mediators of SOCE were finally elucidated. It is now generally accepted that the coupling of the ER/SR membrane protein STIM1 with the plasma membrane protein Orai1 is a major mechanism facilitating SOCE. While the most recent studies on non-voltage-gated Ca2+ signalling and cardiomyocyte hypertrophy have focused on STIM and Orai-mediated pathways, it should be noted that transient receptor potential channels have also been implicated; however, it has been suggested that this may involve Ca2+ entry via LTCC. 3 Clearly, further studies are needed to understand the relative importance of non-voltage-gated and voltage-gated Ca2+ signalling in the heart.In addition to SOCE, there is also growing evidence of another nonvoltage-gated Ca2+ entry pathway, store-independent Ca2+ entry (SICE), primarily characterized as an endogenous arachidonic acid-regulated Ca2+(ARC) channel, which has current/voltage characteristics similar to SOCE, but does not require store depletion. Interestingly, ARC channel activation has been reported to involve a heteromeric assembly of Orai1 and Orai3 4–6 as well as coupling with plasma membrane localized STIM1. 7 It is of note that while STIM and Orai protein families are highly conserved, with invertebrates having only a single Orai protein and vertebrates two Orai proteins, Orai3 appears to be specific for mammalian cells. 6 While there have been a number of studies supporting a role of STIM1 and SOCE in mediating cardiomyocyte hypertrophy, little is known about SICE or ARC activity in the heart. Consequently, the study by Saliba et al., 8 which focuses on the interaction between STIM1 with Orai1 and Orai3 and their role in Ca2+ influx in cardiomyocytes, is both highly novel and timely. They demonstrated for the first time the involvement of Orai3 and ARC channels in non-voltage-gated Ca2+ entry and hypertrophic signalling in rat cardiomyocytes. They found that Orai1, Orai3 and STIM1 were …